AVASTIN INEFFECTIVE: The Food and Drug Administration said Thursday the best-selling cancer drug Avastin should no longer be used in breast cancer patients after failing to extend or improve patient lives in several studies.
CANCER CONTROVERSY: The FDA's decision was favored by many cancer experts but deplored by some cancer patients and physicians, who say Avastin has been a "miracle drug" for a select group of patients.
CHALLENGE: In an unusual move, drugmaker Roche is pushing back against FDA's ruling and has requested a public meeting to discuss Avastin's approval for breast cancer. If FDA accepts the company's requests, it would be the first meeting of its kind.
Rand Paul on NSA: “I Believe What You Do on Your Cell Phone is None of Their Damn Business” | Daniel Doherty
Devastating: 90 Percent of Uninsured Haven't Signed Up For Obamacare, Most Cite High Costs | Guy Benson